F Giraud

2.7k total citations
128 papers, 2.2k citations indexed

About

F Giraud is a scholar working on Genetics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, F Giraud has authored 128 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 46 papers in Molecular Biology and 28 papers in Organic Chemistry. Recurrent topics in F Giraud's work include Genomic variations and chromosomal abnormalities (27 papers), Synthesis and biological activity (14 papers) and Prenatal Screening and Diagnostics (14 papers). F Giraud is often cited by papers focused on Genomic variations and chromosomal abnormalities (27 papers), Synthesis and biological activity (14 papers) and Prenatal Screening and Diagnostics (14 papers). F Giraud collaborates with scholars based in France, Norway and Russia. F Giraud's co-authors include Marie‐Geneviève Mattéi, J. F. Mattéi, Ségolène Aymé, Fabrice Anizon, Pascale Moreau, Isabel Ferreirós-Vidal, Y Aurran, Marc Le Borgne, Vincent Théry and Lionel Nauton and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

F Giraud

119 papers receiving 2.1k citations

Peers

F Giraud

GENET

PPCH

Gerald L. Feldman United States

George H. Thomas United States

U. Claussen Germany

Aurora Sánchez Spain

Roy A. Gravel Canada

Henry L. Nadler United States

Philippe Bouchard France

Humaira Gowher United States

Shinpei Yamaguchi Japan

J. A. Lowden Canada

Gerald L. Feldman United States

F Giraud

1.0k ×0.9

GENET

1.5k ×1.6

442 ×1.2

PPCH

221 ×0.6

156 ×0.5

Citations per year, relative to F Giraud F Giraud (= 1×) peers Gerald L. Feldman

Countries citing papers authored by F Giraud

Since Specialization

Citations

This map shows the geographic impact of F Giraud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Giraud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Giraud more than expected).

Fields of papers citing papers by F Giraud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Giraud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Giraud. The network helps show where F Giraud may publish in the future.

Co-authorship network of co-authors of F Giraud

This figure shows the co-authorship network connecting the top 25 collaborators of F Giraud. A scholar is included among the top collaborators of F Giraud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Giraud. F Giraud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anizon, Fabrice, et al.. (2025). Synthesis and biological activity of 1H-pyrrolo[3,2-g]isoquinolines as Haspin kinase inhibitors. Bioorganic & Medicinal Chemistry. 123. 118157–118157.

Borisevich, Sophia S., Victoria О. Shender, Ksenia S. Anufrieva, et al.. (2024). The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells. Cancers. 16(4). 834–834. 2 indexed citations

Frazier, T M, Elisabeth Pereira, Reidun Aesöy, et al.. (2024). Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles. European Journal of Medicinal Chemistry. 269. 116352–116352. 2 indexed citations

Zeinyeh, Waël, Blandine Baratte, Stefan Knapp, et al.. (2022). Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity. European Journal of Medicinal Chemistry. 236. 114369–114369. 7 indexed citations

Hérault, Karine, F Giraud, Alain Artola, et al.. (2021). Improved potency of pyridin-2(1H)one derivatives for the treatment of mechanical allodynia. European Journal of Medicinal Chemistry. 225. 113748–113748. 2 indexed citations

Aesöy, Reidun, Øystein Bruserud, Annette K. Brenner, et al.. (2019). A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 18(3). 567–578. 15 indexed citations

Zeinyeh, Waël, Stefan Knapp, Deep Chatterjee, et al.. (2019). New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. European Journal of Medicinal Chemistry. 166. 304–317. 32 indexed citations

Zeinyeh, Waël, Lionel Nauton, Nadège Loaëc, et al.. (2016). Synthesis and preliminary in vitro kinase inhibition evaluation of new diversely substituted pyrido[3,4-g]quinazoline derivatives. Bioorganic & Medicinal Chemistry Letters. 26(17). 4327–4329. 17 indexed citations

Moreau, Pascale, et al.. (2016). Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety. Recent Patents on Anti-Cancer Drug Discovery. 11(3). 309–321. 7 indexed citations

10.

Giraud, F, et al.. (2015). Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells. Bioorganic & Medicinal Chemistry. 23(22). 7313–7323. 6 indexed citations

11.

Giraud, F, Lionel Nauton, Vincent Théry, et al.. (2014). New N-1,N-10-bridged pyrrolo[2,3-a]carbazole-3-carbaldehydes: Synthesis and biological activities. Bioorganic Chemistry. 57. 108–115. 15 indexed citations

12.

Gavara, Laurent, F Giraud, Lionel Nauton, et al.. (2014). Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition. Bioorganic & Medicinal Chemistry. 22(17). 4704–4710. 15 indexed citations

13.

Giraud, F, et al.. (2010). Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities. Bioorganic & Medicinal Chemistry Letters. 20(17). 5203–5206. 7 indexed citations

14.

Giraud, F, Cédric Logé, Marc Le Borgne, et al.. (2009). Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols. Bioorganic & Medicinal Chemistry Letters. 19(20). 5833–5836. 24 indexed citations

15.

Giraud, F, Cédric Logé, Fabrice Pagniez, et al.. (2008). Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorganic & Medicinal Chemistry Letters. 18(6). 1820–1824. 32 indexed citations

16.

Giraud, F, Cédric Logé, Fabrice Pagniez, et al.. (2008). Synthesis and structure–activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorganic & Medicinal Chemistry Letters. 19(2). 301–304. 40 indexed citations

17.

Aymé, Ségolène, et al.. (1993). Diffusion of information about genetic risk within families. Neuromuscular Disorders. 3(5-6). 571–574. 32 indexed citations

18.

Mattéi, Marie‐Geneviève, et al.. (1981). Variabilite interindividuelle des associations entre chromosomes acrocentriques.. 29(2). 2 indexed citations

19.

Giraud, F, et al.. (1977). [Partial trisomy 13 due to maternal translocation t(2;13)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(3). 203–8. 16 indexed citations

20.

Giraud, F, et al.. (1975). [The chromosome 13 in ring syndrome].. PubMed. 30(4). 339–49. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact